<?xml version="1.0" encoding="UTF-8"?>
<p id="Par87">Many CMGs recommended the addition of vancomycin [
 <xref ref-type="bibr" rid="CR2">2</xref>, 
 <xref ref-type="bibr" rid="CR5">5</xref>, 
 <xref ref-type="bibr" rid="CR34">34</xref>–
 <xref ref-type="bibr" rid="CR37">37</xref>, 
 <xref ref-type="bibr" rid="CR39">39</xref>, 
 <xref ref-type="bibr" rid="CR40">40</xref>] alternatively rifampicin [
 <xref ref-type="bibr" rid="CR2">2</xref>, 
 <xref ref-type="bibr" rid="CR5">5</xref>, 
 <xref ref-type="bibr" rid="CR37">37</xref>, 
 <xref ref-type="bibr" rid="CR39">39</xref>] if there is suspicion of reduced sensitivity to penicillin, except for neonates. However, the CMGs produced by IDSA (USA) and NICE (UK) gave different advice. The first recommended vancomycin to everyone except neonates (&lt; 28 days old) [
 <xref ref-type="bibr" rid="CR44">44</xref>], whereas the CMG by NICE recommended vancomycin to all returning travellers or those with recent prolonged or multiple exposure to antibiotics within the past 3 months, to cover risk of penicillin-resistant strains of 
 <italic>S. pneumoniae</italic> [
 <xref ref-type="bibr" rid="CR24">24</xref>].
</p>
